Bioidentical Hormone Therapy Ltd
13472110
Healthy
- Loss before tax (-10)
- 1 outstanding charge (-2)
Details
Compliance
Last accounts
31/12/2024
total exemption full
Next accounts due
30/09/2026
Confirmation statement
Last: 01/07/2025
Due 15/07/2026
Industry
Officers
Former
director · Resigned 28/10/2025
Persons with Significant Control
Dr Martin James Kinsella
British · England · Age 45
Ellenborough House, Wellington Street, Cheltenham, GL50 1YD
Notified 12/07/2023
Mrs Hanna Kinsella
British · United Kingdom · Age 38
Ellenborough House, Wellington Street, Cheltenham, GL50 1YD
Notified 12/07/2023
Former PSCs
Mjk Medical Limited
Ceased 12/07/2023
Charges1 outstanding
Hmkinsella Limited
Change History
Active
CHELTENHAM
Private Limited Company
ELLENBOROUGH HOUSE
CompanyRankvs 42965+ SIC 86900 peers34
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2024
Net Worth
£100
Balance sheet strength
Cash
£13k
Cash in the bank
Profit Before Tax
-£179k
Bottom line earnings
Net Current Assets
-£291k
Working capital
Current Assets
£56k
Current Liabilities
£348k
Fixed Assets
£517
Debtors
£44k
Admin Expenses
£558k
Profit After Tax
-£179k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 0.16 | — |
| 2024 | 0.25 | +£7k |
| 2023 | 0.09 | -£68k |
| 2022 | 0.01 | — |
Derived from filed accounts. Not audited figures.